Intellectual Property India Publishes Patent Application for 'Therapeutic Oligonucleotide-Containing Pharmaceutical Compositions And Dosing Regimens Using The Same' Filed by Eli Lilly And Company

MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517066465 A) filed by Eli Lilly And Company, Indianapolis, on July 11, for 'therapeutic oligonucleotide-containing pharmaceutical compositions and dosing regimens using the same.'

Inventor(s) include Garg, Ashish; Kaur, Amritpreet; Krege, John Henry; Ma, Xiaosu; Ni, Wei; and Haw, Helle Linnebjerg.

The application for the patent was published on Aug. 1, under issue no. 31/2025.

According to the abstract released by the Intellectual Property India: "Pharmaceutical compositions are disclosed that include a double-stranded RNAi agent that modulates LPA expression or its pharmaceutically acceptable salt thereof in water. Doses and dosing regimens for s...